1. Show article details.

    Medical Marijuana Inc.’s New Real Scientific Hemp Oil™ Liquid Product Line Now Available for Import Into Brazilian Market

    GlobeNewswire – 9:00 AM ET 11/23/2015

    Medical Marijuana, Inc. (MJNA) is pleased to announce the immediate release of its new line of Real Scientific Hemp Oil™ products with medium-chain triglyceride oil for import into Brazil, through its exclusive distributor HempMeds Brasil™. This new liquid product line is an all-natural, non-GMO hemp oil formulation with MCT oil.

  2. Show article details.

    ANVISA – Brazil’s Government Health Agency – Approves Patient’s Request for Medical Marijuana, Inc.’s Real Scientific Hemp Oil™ for a New Indication: Parkinson’s Disease

    GlobeNewswire – 9:00 AM ET 11/18/2015

    Medical Marijuana (MJNA), Inc.  is pleased to announce to shareholders and to the public that its flagship product Real Scientific Hemp Oil™ has again made world history as a cannabis product to be approved on a case-by-case basis for Parkinson’s disease by the Brazilian Government Health Agency ANVISA – which is responsible for approving citizen importation of medicines and botanical remedies from ou...

  3. Show article details.

    ABC 10 News: Brazil Government Now Medical Marijuana, Inc.’s Largest International Client With Cannabidiol (CBD) Hemp Oil Export Including RSHO

    GlobeNewswire – 9:00 AM ET 10/27/2015

    Real Scientific Hemp Oil™, made by Medical Marijuana, Inc. (MJNA), is making headline news as the U.S.’s first and largest legal hemp-based cannabis export. A photo accompanying this release is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/803fc12a-d7fb-432f-a5d2-e983431adf52.

  4. Show article details.

    Kannaway, an MJNA Company, Innovates the MLM Industry With New Comp Plan and Proprietary Hemp Oil CBD Products

    GlobeNewswire – 9:00 AM ET 10/26/2015

    Kannaway, LLC, the first award-winning hemp lifestyle relationship marketing company to offer proprietary natural hemp oil products is proud to announce a new compensation plan that is significantly different than any other in the industry.

  5. Show article details.

    Medical Marijuana Inc. and Subsidiary MPSI Featured in Bloomberg, Time.com, Fortune and Yahoo Articles

    GlobeNewswire – 9:00 AM ET 10/13/2015

    Medical Marijuana, Inc. (MJNA) is leading by example as it fosters growth and opportunity in the rapidly expanding cannabis industry. The Bloomberg article, which was picked up by Fortune magazine and Time.com, references “casinos a model for handling $3 billion in industry revenue.

  6. Show article details.

    Medical Marijuana, Inc. CEO Stuart Titus to Present on Hemp Industry Innovations on the Cannabis Investor Webcast

    GlobeNewswire – 9:00 AM ET 10/08/2015

    Medical Marijuana, Inc. (MJNA), the first-ever publicly traded U.S. cannabis company, is pleased to announce to shareholders and the general public that Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. (MJNA) will be presenting on the Cannabis Investor Webcast on Thursday, October 8 at 4:00 – 4:45 PM ET.

  7. Show article details.

    Medical Marijuana Inc.'s MPSI Provides Security at National Cannabis Summit in Colorado

    GlobeNewswire – 9:00 AM ET 10/05/2015

    In a highly competitive and growing field of security services companies supporting the U.S. legal cannabis industry, Medical Marijuana (MJNA), Inc.’s  subsidiary, Wellness Managed Services’ MPS International, rose above the rest.

  8. Show article details.

    Medical Marijuana, Inc. Receives Twelve Medical Product Registrations and Approvals

    GlobeNewswire – 9:00 AM ET 09/24/2015

    Medical Marijuana, Inc. (MJNA) is announcing the next milestone achievement in their plan to actively and aggressively register a pipeline of cannabis products for healthcare professionals and pharmacies. For the first time, twelve of Medical Marijuana, Inc.'s (MJNA) products received overseas registration and approval as international medicinal products.

  9. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Real Scientific Hemp Oil [RSHO] Signs Landmark First Pharmaceutical Sales and Distribution Agreement as Part of Its Global Expansion

    GlobeNewswire – 9:00 AM ET 09/23/2015

    As the U.S. territories and Caribbean Islands wait for medical marijuana to make its debut, Medical Marijuana, Inc. (MJNA) is proud to immediately offer residents an alternative: Real Scientific Hemp Oil [RSHO]™. Photos accompanying this release are available at. http://www.globenewswire.com/newsroom/prs/?pkgid=36039. http://www.globenewswire.com/newsroom/prs/?pkgid=36040. http://www.globenewswire.com...

  10. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Dixie Botanicals(TM) Unveils Dixie Stix CBD Hemp Oil at Los Angeles Global Cannabis Expo; Addresses Industry Challenge: Standardization

    GlobeNewswire – 9:00 AM ET 09/16/2015

    One of the cannabis industry's most visible brands, Dixie Botanicals™, is proud to announce their newest hemp cannabidiol oil whole food product: Dixie Stix.

  11. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Real Scientific Hemp Oil [RSHO] Launches New CBD Hemp Oil Product Lines at CWCB Expo in Los Angeles; CEO Dr. Stuart Titus Featured Guest Speaker

    GlobeNewswire – 9:00 AM ET 09/15/2015

    One of the world's most trusted brands of hemp cannabidiol oil, Real Scientific Hemp Oil™ or [RSHO]™ has a new look.

  12. Show article details.

    Medical Marijuana, Inc.'s HempMeds(R) Signs U.S. Manufacturer Sales Agreement for Over $2,500,000 - Ships First Two Months Supply of 12 Month Contract

    GlobeNewswire – 9:00 AM ET 09/09/2015

    HempMeds®, a Medical Marijuana, Inc. (MJNA) portfolio company and the Company's master distributor, is pleased to announce to shareholders and the public that it has signed a U.S. manufacturer for sourcing of its Gold Label cannabidiol hemp oil brand Real Scientific Hemp Oil™. The sourcing agreement is for a minimum of $2,500,000 USD for a 12-month period.

  13. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Cannabidiol (CBD) Hemp Oil Featured in Documentary Short at Film Festival

    GlobeNewswire – 9:00 AM ET 09/04/2015

    At eight months-old, her body was riddled with chronic seizures and tumors. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=35836. Enduring multiple operations and medications that created swelling in her body like a balloon, the simplest task such as breathing was labored and Sadie could be heard struggling to live throughout the Higuera's home.

  14. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s Kannaway Announces Expansion of Executive Leadership Team

    GlobeNewswire – 9:00 AM ET 08/27/2015

    Medical Marijuana, Inc.'s Kannaway is proud to announce the addition of Mr. Bradley J. Tayles as Vice President of Operations. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=35610. "We are very fortunate that Brad Tayles joined the Kannaway organization and welcome him to our team," states Jeff Rogers, Chief Executive Officer of Kannaway.

  15. Show article details.

    Medical Marijuana, Inc's Portfolio Investment Company Kannalife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents

    GlobeNewswire – 9:00 AM ET 08/14/2015

    Medical Marijuana, Inc. (MJNA) portfolio investment company Kannalife Sciences, Inc. has announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized 1,3-Benzene Diols and Their Method of Use for the Treatment of Hepatic Encephalopathy'. Both hepatic encephalopathy and chronic traumatic encephalopathy are oxidative stress related diseases.

  16. Show article details.

    MJNA's Investment Company AXIM Biotech Announces Clinical Trial Launch of MedChew RX for Treatment of Pain and Spasticity in Multiple Sclerosis and Development of Pharmaceutical Cannabis Chewing Gum

    GlobeNewswire – 9:00 AM ET 08/13/2015

    Medical Marijuana, Inc. (MJNA) is an agricultural hemp industry innovator that sources, evaluates, invests in and acquires value-adding companies with a focus on industrial hemp. Pain management medications are coming under increased scrutiny, as is evidenced by FDA warnings on the safety of nonsteroidal anti-inflammatory drugs from July 2015.

  17. Show article details.

    Medical Marijuana, Inc.'s HempMeds Expands Into Asian Market With Its First Distributor Agreeing to an Initial Purchase Order of 2,000,000 USD in Hemp CBD Oil Products

    GlobeNewswire – 9:00 AM ET 08/12/2015

    HempMeds®, an MJNA portfolio company and the Company's master distributor, is pleased to announce to shareholders and the public that it is expanding sales through HempMeds® South Korea, an exclusive distributor, responsible for marketing and sales of the Company's cannabidiol hemp oil products.

  18. Show article details.

    HempMeds, A Medical Marijuana, Inc. - Hemp CBD Oil Subsidiary, Named Title Sponsor at Hope4Harper's "Run4Hope" 5K Fundraiser for CDKL5 Epilepsy Research

    GlobeNewswire – 3:30 PM ET 08/11/2015

    HempMeds® is proud to announce it will be this year's title sponsor of Hope4Harper's 4th Annual "Run4Hope" 1-Mile Kids Fun Run & 5K that takes place Saturday, September 12 at Andy Brown Park East in Coppell, TX. The organization raises funds to research Cyclin Dependent Kinase Like 5, CDKL5, epilepsy and seizure-related disorders.

  19. Show article details.

    Photo Release -- Medical Marijuana, Inc.'s HempMeds Featured on NBC 7 Discussing Cannabis in Pro Sports From Growing Industry Hub: San Diego

    GlobeNewswire – 1:49 PM ET 08/11/2015

    San Diego's economic development is being fueled by one of the oldest plants on the planet: cannabis. A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=35086.

  20. Show article details.

    Photo Release -- Medical Marijuana, Inc. and HempMeds Brasil(TM) Celebrate 15 Year-Old Boy's Free Access to RSHO Hemp CBD Oil -- Subsidized by the Brazilian Government

    GlobeNewswire – 9:00 AM ET 08/05/2015

    Medical Marijuana, Inc. (MJNA) is proud to announce, through its partnership with HempMeds Brasil™, that the Brazilian government has subsidized the cost of a 30-day supply of Real Scientific Hemp Oil™ (RSHO, the cannabidiol hemp oil brand) for 15 year-old Gabriel César do Amaral.


Today's and Upcoming Events

No events in the next 90 days

Past Events (last 90 days)

No events in the past 90 days

Data provided by Wall Street Horizon, Inc. © 2015

Technical Events

Technical Analysis

As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.

Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.